Transcranial Magnetic Stimulation for Youth With Treatment-Resistant Major Depressive Disorder
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Major Depressive Disorder
Related studies linked through entity extraction aliases.
In-patient SCC TMS
- Status
- RECRUITING
- Phase
- NA
INflammation-based Stratification for Immune-Targeted Augmentation in Major Depressive Disorder
- Status
- RECRUITING
- Phase
- PHASE3
IM and IV SPL026 Drug Product in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
"Mamá, te Entiendo" App-based Intervention for Reducing Depressive Symptoms in Postpartum Women
- Status
- UNKNOWN
- Phase
- NA
Impact of Covid-19 Pandemic on Patients Receiving Continuation or Maintenance Electroconvulsive Therapy
- Status
- COMPLETED
- Phase
- N/A
Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression
- Status
- RECRUITING
- Phase
- N/A
Predictors of Intravenous Ketamine Response in TRD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression
- Status
- COMPLETED
- Phase
- PHASE4
Integrated Suicide & Trauma Therapy for Suicide Risk
- Status
- RECRUITING
- Phase
- NA
Efficacy and Safety of Intradermal Acupuncture for Major Depressive Disorder
- Status
- RECRUITING
- Phase
- NA
Clinical Validation Study for EDIT-B Test: an Aid for Differential Diagnosis of Bipolar Disorder, Based on RNA Editing Blood Biomarkers
- Status
- COMPLETED
- Phase
- N/A
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
- Status
- RECRUITING
- Phase
- PHASE3
PET Synaptogenesis After Psilocybin In DEpression Recovery
- Status
- WITHDRAWN
- Phase
- PHASE2
Evaluating tDCS Brain-stimulation in Depression Using MRI
- Status
- RECRUITING
- Phase
- NA
Multiple Ascending Dose and Electroencephalography Trial of GATE-202 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Effect of SSRIs on Response to Psilocybin Therapy
- Status
- WITHDRAWN
- Phase
- PHASE2
A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE2
D-Cycloserine Augmentation of Intermittent Theta Burst Stimulation (iTBS) in Depression (COGENT)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Treatment Response Biomarkers in MDD
- Status
- RECRUITING
- Phase
- N/A